Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 370-383
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Direct effects | Indirect effects |
CMV syndrome | Acute allograft rejection |
Fever | Chronic allograft rejection |
Myelosuppression | Vanishing bile duct syndrome |
Malaise | Chronic ductopenic rejection |
Tissue-invasive CMV disease1 | Hepatitis C virus recurrence |
Gastrointestinal disease | Allograft hepatitis, fibrosis |
(colitis, esophagitis, gastritis, | Allograft failure |
enteritis) | Opportunistic and other infections |
Hepatitis | Fungal superinfection |
Pneumonitis | Nocardiosis |
CNS disease | Bacterial superinfection |
Retinitis | Epstein-Barr virus and PTLD |
Mortality | HHV-6 and HHV-7 infections |
Vascular thrombosis | |
New onset diabetes mellitus | |
Mortality |
- Citation: Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 2014; 6(6): 370-383
- URL: https://www.wjgnet.com/1948-5182/full/v6/i6/370.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i6.370